Aiba Takeshi, Hesketh Geoffrey G, Liu Ting, Carlisle Rachael, Villa-Abrille Maria Celeste, O'Rourke Brian, Akar Fadi G, Tomaselli Gordon F
Division of Cardiology, Johns Hopkins University School of Medicine, 720 Rutland Ave., Ross 844, Baltimore, MD 21205, USA.
Cardiovasc Res. 2010 Feb 1;85(3):454-63. doi: 10.1093/cvr/cvp324. Epub 2009 Oct 1.
Calmodulin (CaM) regulates Na+ channel gating through binding to an IQ-like motif in the C-terminus. Ca2+/CaM-dependent protein kinase II (CaMKII) regulates Ca2+ handling, and chronic overactivity of CaMKII is associated with left ventricular hypertrophy and dysfunction and lethal arrhythmias. However, the acute effects of Ca2+/CaM and CaMKII on cardiac Na+ channels are not fully understood.
Purified Na(V)1.5-glutathione-S-transferase fusion peptides were phosphorylated in vitro by CaMKII predominantly on the I-II linker. Whole-cell voltage-clamp was used to measure Na+ current (I(Na)) in isolated guinea-pig ventricular myocytes in the absence or presence of CaM or CaMKII in the pipette solution. CaMKII shifted the voltage dependence of Na+ channel availability by approximately +5 mV, hastened recovery from inactivation, decreased entry into intermediate or slow inactivation, and increased persistent (late) current, but did not change I(Na) decay. These CaMKII-induced changes of Na+ channel gating were completely abolished by a specific CaMKII inhibitor, autocamtide-2-related inhibitory peptide (AIP). Ca2+/CaM alone reproduced the CaMKII-induced changes of I(Na) availability and the fraction of channels undergoing slow inactivation, but did not alter recovery from inactivation or the magnitude of the late current. Furthermore, the CaM-induced changes were also completely abolished by AIP. On the other hand, cAMP-dependent protein kinase A inhibitors did not abolish the CaM/CaMKII-induced alterations of I(Na) function.
Ca2+/CaM and CaMKII have distinct effects on the inactivation phenotype of cardiac Na+ channels. The differences are consistent with CaM-independent effects of CaMKII on cardiac Na+ channel gating.
钙调蛋白(CaM)通过与C末端的类IQ基序结合来调节钠通道门控。钙/钙调蛋白依赖性蛋白激酶II(CaMKII)调节钙处理,而CaMKII的慢性过度激活与左心室肥厚、功能障碍及致死性心律失常相关。然而,钙/钙调蛋白和CaMKII对心脏钠通道的急性作用尚未完全明确。
纯化的Na(V)1.5-谷胱甘肽-S-转移酶融合肽在体外主要由CaMKII在I-II连接区磷酸化。采用全细胞电压钳技术,在移液管溶液中不存在或存在CaM或CaMKII的情况下,测量分离的豚鼠心室肌细胞中的钠电流(I(Na))。CaMKII使钠通道可用性的电压依赖性向正方向移动约5 mV,加速失活后的恢复,减少进入中间或缓慢失活状态,增加持续性(晚期)电流,但不改变I(Na)的衰减。一种特异性CaMKII抑制剂,自身抑制肽-2相关抑制肽(AIP)可完全消除CaMKII诱导的这些钠通道门控变化。单独的钙/钙调蛋白可重现CaMKII诱导的I(Na)可用性变化以及经历缓慢失活的通道比例,但不改变失活后的恢复或晚期电流的大小。此外,AIP也可完全消除钙调蛋白诱导的变化。另一方面,环磷酸腺苷依赖性蛋白激酶A抑制剂不能消除钙调蛋白/CaMKII诱导的I(Na)功能改变。
钙/钙调蛋白和CaMKII对心脏钠通道的失活表型有不同影响。这些差异与CaMKII对心脏钠通道门控的非钙调蛋白依赖性作用一致。